National Cancer Institute and Gritstone bio team up on vaccine
Neoantigen vaccine candidate, SLATE-KRAS has demonstrated early evidence of efficacy
Read More
Tag: NCI
CR UK, CRT Pioneer Fund and the NCI link on RAS
Cancer Research UK and the Cancer Research Technology Pioneer Fund are committing £2.5 million in collaboration with the US’ National Cancer Institute to tackle RAS, one of the most common driving mutations in aggressive, hard to treat cancers.
Read More
Research groups unite to create bank of cancer models
Four research powerhouses have come together to launch an international project aiming to set up a large, globally accessible, bank of new cancer cell culture models for the research.
Read More
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
